These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 19522762)

  • 1. Influence of tumour condition on the macrophage activity in Candida albicans infection.
    Venturini J; de Camargo MR; Félix MC; Vilani-Moreno FR; de Arruda MS
    Scand J Immunol; 2009 Jul; 70(1):10-7. PubMed ID: 19522762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of macrophage cytokine profiles during solid tumor progression: susceptibility to Candida albicans infection.
    Camargo MR; Venturini J; Vilani-Moreno FR; Arruda MS
    BMC Infect Dis; 2009 Jun; 9():98. PubMed ID: 19534779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low dose of Concanavalin-A enhances innate immune response and prevents liver injury in mice infected with Candida albicans.
    Conchon-Costa I; Loyola W; Gaziri LC; Custódio LA; Felipe I
    FEMS Immunol Med Microbiol; 2007 Apr; 49(3):330-6. PubMed ID: 17284281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased tumour necrosis factor-alpha production, higher mannose receptor activity and ability to kill Candida by concanavalin-A-activated macrophages.
    Geraldino TH; de Vito E; Custódio LA; Conchon-Costa I; Gaziri LC; Felipe I; Loyola W; Bonifácio KL
    FEMS Immunol Med Microbiol; 2010 Jun; 59(1):11-7. PubMed ID: 20236321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fas-FasL interactions modulate host defense against systemic Candida albicans infection.
    Netea MG; van Der Meer JW; Meis JF; Kullberg BJ
    J Infect Dis; 1999 Nov; 180(5):1648-55. PubMed ID: 10515828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired activity of phagocytic cells in Candida albicans infection after exposure to chronic varied stress.
    Rodriguez-Galán MC; Correa SG; Cejas H; Sotomayor CE
    Neuroimmunomodulation; 2001; 9(4):193-202. PubMed ID: 11847481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of TLR1 and TLR6 in the host defense against disseminated candidiasis.
    Netea MG; van de Veerdonk F; Verschueren I; van der Meer JW; Kullberg BJ
    FEMS Immunol Med Microbiol; 2008 Jan; 52(1):118-23. PubMed ID: 18036178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of aging on murine neutrophil and macrophage function against Candida albicans.
    Murciano C; Yáñez A; O'Connor JE; Gozalbo D; Gil ML
    FEMS Immunol Med Microbiol; 2008 Jul; 53(2):214-21. PubMed ID: 18445021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection of C3H/HE J mice from development of Candida albicans infection by oral administration of Juzen-taiho-to and its component, Ginseng radix: possible roles of macrophages in the host defense mechanisms.
    Akagawa G; Abe S; Tansho S; Uchida K; Yamaguchi H
    Immunopharmacol Immunotoxicol; 1996 Feb; 18(1):73-89. PubMed ID: 8683040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diazepam effects on Ehrlich tumor growth and macrophage activity in mice.
    Sakai M; Fonseca ES; Dagli ML; Palermo-Neto J
    Life Sci; 2006 Mar; 78(16):1777-83. PubMed ID: 16257421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis of phagocytic cells induced by Candida albicans and production of IL-10.
    Gasparoto TH; Gaziri LC; Burger E; de Almeida RS; Felipe I
    FEMS Immunol Med Microbiol; 2004 Oct; 42(2):219-24. PubMed ID: 15364107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mice lacking both G-CSF and IL-6 are more susceptible to Candida albicans infection: critical role of neutrophils in defense against Candida albicans.
    Basu S; Quilici C; Zhang HH; Grail D; Dunn AR
    Growth Factors; 2008 Feb; 26(1):23-34. PubMed ID: 18365876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced resistance against systemic Candida albicans infection in mice treated with C. albicans DNA.
    Dimitrova P; Yordanov M; Danova S; Ivanovska N
    FEMS Immunol Med Microbiol; 2008 Jul; 53(2):231-6. PubMed ID: 18507679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased susceptibility of complement factor B/C2 double knockout mice and mannan-binding lectin knockout mice to systemic infection with Candida albicans.
    Held K; Thiel S; Loos M; Petry F
    Mol Immunol; 2008 Sep; 45(15):3934-41. PubMed ID: 18672286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of Candida albicans morphogenesis by tumor necrosis factor-alpha and potential for treatment of oral candidiasis.
    Ohta H; Tanimoto T; Taniai M; Taniguchi M; Ariyasu T; Arai S; Ohta T; Fukuda S
    In Vivo; 2007; 21(1):25-32. PubMed ID: 17354610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of protection against candidiasis in tumor-bearing mice by vaccination with Candida albicans ribosomes.
    Segal E; Spungin A; Levy R; Barr-Nea L
    J Med Vet Mycol; 1987 Dec; 25(6):355-63. PubMed ID: 3325628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene targeting demonstrates that inducible nitric oxide synthase is not essential for resistance to oral candidiasis in mice, or for killing of Candida albicans by macrophages in vitro.
    Farah CS; Saunus JM; Hu Y; Kazoullis A; Ashman RB
    Oral Microbiol Immunol; 2009 Feb; 24(1):83-8. PubMed ID: 19121076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chloroquine is therapeutic in murine experimental model of paracoccidioidomycosis.
    Dias-Melicio LA; Calvi SA; Bordon AP; Golim MA; Peraçoli MT; Soares AM
    FEMS Immunol Med Microbiol; 2007 Jun; 50(1):133-43. PubMed ID: 17456179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunomodulating effect of electromagnetic waves on production of tumor necrosis factor in mice with various rates of neoplasm growth].
    Glushkova OV; Novoselova EG; Sinotova OA; Vrublevskaia VV; Fesenko EE
    Biofizika; 2002; 47(2):376-81. PubMed ID: 11969180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lactoferrin feeding augments peritoneal macrophage activities in mice intraperitoneally injected with inactivated Candida albicans.
    Wakabayashi H; Takakura N; Teraguchi S; Tamura Y
    Microbiol Immunol; 2003; 47(1):37-43. PubMed ID: 12636251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.